These final results, together with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two assist the concept of concentrating on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for op